NCT02069106View on ClinicalTrials.gov

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2014

Conditions
Mixed Hyperlipoproteinemia
Interventions
DIETARY_SUPPLEMENT

Pro-Omega LDL

OTHER

Placebo

Sponsors

Lead Sponsor

Nordic Pharma, USA
All Listed Sponsors
collaborator

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK

lead

Nordic Pharma, USA

INDUSTRY

NCT02069106 - Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction | Biotech Hunter | Biotech Hunter